
Immunovant, Inc.
USD31.15
+0.23 (+0.74%)
CEO
Eric Venker
IPO Date
2019-06-21
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$30.82
Prev. Close
$30.92
Day Low
$30.33
Day High
$31.31
52W Low
$14.32
52W High
$36.28
Market Cap
$6.40B
Volume
1.85M
| 21 May 2026 |
| B of A Securities |
| Buy |
| Buy |
| maintain |
| 15 Apr 2026 | Goldman Sachs | Neutral | Neutral | maintain |
| 10 Feb 2026 | HC Wainwright & Co. | Buy | Buy | maintain |
| 9 Feb 2026 | Guggenheim | Buy | Buy | maintain |
| 8 Jan 2026 | Truist Securities | Hold | Hold | maintain |
| 6 Jan 2026 | Wolfe Research | Peer Perform | Outperform | upgrade |
| 15 Dec 2025 | Goldman Sachs | Neutral | Neutral | maintain |